Ron Goeree

13.1k total citations · 1 hit paper
252 papers, 9.4k citations indexed

About

Ron Goeree is a scholar working on Economics and Econometrics, Surgery and General Health Professions. According to data from OpenAlex, Ron Goeree has authored 252 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Economics and Econometrics, 55 papers in Surgery and 48 papers in General Health Professions. Recurrent topics in Ron Goeree's work include Health Systems, Economic Evaluations, Quality of Life (92 papers), Healthcare Policy and Management (27 papers) and Healthcare cost, quality, practices (24 papers). Ron Goeree is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (92 papers), Healthcare Policy and Management (27 papers) and Healthcare cost, quality, practices (24 papers). Ron Goeree collaborates with scholars based in Canada, United States and United Kingdom. Ron Goeree's co-authors include Jean‐Éric Tarride, Gord Blackhouse, Daria O’Reilly, B O’Brien, Robert Hopkins, Bernie J. OʼBrien, Andrew Briggs, Feng Xie, James M. Bowen and Jonathan D. Adachi and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Ron Goeree

248 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of PCI on Quality of Life in Patients with Stable Coronary Disease

2008 434 citations Ron Goeree et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron Goeree Canada	49	2.3k	2.3k	1.7k	1.6k	1.1k	252	9.4k
Doug Coyle Canada	51	1.4k 0.6×	1.6k 0.7×	1.5k 0.9×	1.1k 0.7×	1.0k 1.0×	298	10.7k
Lieven Annemans Belgium	46	1.7k 0.7×	2.3k 1.0×	1.4k 0.8×	1.8k 1.2×	1.7k 1.5×	440	11.3k
Joel Singer Canada	40	2.4k 1.0×	1.2k 0.5×	1.8k 1.0×	1.1k 0.7×	2.1k 1.9×	141	12.0k
Danny Liew Australia	52	2.5k 1.1×	1.7k 0.8×	2.1k 1.2×	1.2k 0.8×	1.6k 1.4×	520	12.4k
Andreas Laupacis Canada	42	2.7k 1.2×	1.2k 0.5×	1.2k 0.7×	1.8k 1.1×	1.8k 1.6×	115	12.3k
Til Stürmer‎ United States	60	2.3k 1.0×	2.6k 1.1×	1.4k 0.8×	775 0.5×	1.8k 1.6×	334	14.5k
Shunichi Fukuhara Japan	53	2.1k 0.9×	1.6k 0.7×	1.4k 0.8×	1.9k 1.2×	1.7k 1.6×	372	13.4k
Elizabeth A. Chrischilles United States	52	1.9k 0.8×	1.6k 0.7×	1.2k 0.7×	1.2k 0.8×	1.1k 1.0×	238	10.4k
Kathleen Bennett Ireland	57	1.3k 0.6×	2.2k 0.9×	2.0k 1.2×	1.6k 1.0×	1.7k 1.6×	481	12.1k
John M. Esdaile Canada	63	2.1k 0.9×	1.0k 0.4×	692 0.4×	1.1k 0.7×	740 0.7×	272	13.6k

Countries citing papers authored by Ron Goeree

Since Specialization

Citations

This map shows the geographic impact of Ron Goeree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Goeree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Goeree more than expected).

Fields of papers citing papers by Ron Goeree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Goeree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Goeree. The network helps show where Ron Goeree may publish in the future.

Co-authorship network of co-authors of Ron Goeree

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Goeree. A scholar is included among the top collaborators of Ron Goeree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Goeree. Ron Goeree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goeree, Ron, et al.. (2022). Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada. Archives of Osteoporosis. 17(1). 71–71. 6 indexed citations

Ahmed, Iqbal Ike K., et al.. (2018). PMD109 - A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IMPLANTED AT TIME OF CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA. Value in Health. 21. S261–S261. 1 indexed citations

Tsoi, Bernice, Leo E. Akioyamen, Ashley Bonner, et al.. (2017). Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung and Circulation. 27(6). 666–682. 15 indexed citations

Goeree, Ron, et al.. (2016). Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes. Journal of Medical Economics. 19(6). 630–644. 58 indexed citations

Dunlop, W., C. Daniel Mullins, Ron Goeree, et al.. (2016). BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles. PharmacoEconomics. 34(10). 1051–1065. 11 indexed citations

Tsoi, Bernice, et al.. (2015). Systematic narrative review of decision frameworks to select the appropriate modelling approaches for health economic evaluations. BMC Research Notes. 8(1). 244–244. 8 indexed citations

Assasi, Nazila, Lisa Schwartz, Jean‐Éric Tarride, Kaitryn Campbell, & Ron Goeree. (2014). A systematic review of methodological frameworks for evaluation of ethical considerations in health technology assessment. Value in Health. 17(3). A200–A200.

Hopkins, Robert, et al.. (2014). Burden of illness of diabetic foot ulcers in Canada. Value in Health. 17(3). A246–A246. 2 indexed citations

Masucci, Luca & Ron Goeree. (2013). Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis.. PubMed Central. 16 indexed citations

10.

Assasi, Nazila, Lisa Schwartz, Jean‐Éric Tarride, Ron Goeree, & Feng Xie. (2012). Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review. Genetic Testing and Molecular Biomarkers. 16(11). 1322–1335. 12 indexed citations

11.

Pullenayegum, Eleanor, et al.. (2011). Bayesian Hierarchical Models Combining Different Study Types and Adjusting for Covariate Imbalances: A Simulation Study to Assess Model Performance. PLoS ONE. 6(10). e25635–e25635. 15 indexed citations

12.

O’Reilly, Daria, Jean‐Éric Tarride, Ron Goeree, Cynthia Lokker, & K. Ann McKibbon. (2011). The economics of health information technology in medication management: a systematic review of economic evaluations. Journal of the American Medical Informatics Association. 19(3). 423–438. 35 indexed citations

13.

Tarride, Jean‐Éric, et al.. (2011). PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS. Value in Health. 14(3). A119–A120. 1 indexed citations

14.

Hopkins, Robert, Ron Goeree, & Christopher J. Longo. (2010). Estimating the National Wage Loss from Cancer in Canada. Current Oncology. 17(2). 40–49. 25 indexed citations

15.

Tarride, Jean‐Éric, Gord Blackhouse, Teresa Novick, et al.. (2008). Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. Journal of Vascular Surgery. 48(4). 779–787. 38 indexed citations

16.

Skedgel, Chris, et al.. (2007). The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty. Journal of Bone and Joint Surgery. 89(4). 819–828. 28 indexed citations

17.

Guyatt, Gordon, Mika Nonoyama, Christina Lacchetti, et al.. (2005). A Randomized Trial of Strategies for Assessing Eligibility for Long-Term Domiciliary Oxygen Therapy. American Journal of Respiratory and Critical Care Medicine. 172(5). 573–580. 40 indexed citations

18.

OʼBrien, Bernie J., Ron Goeree, Margaret Hux, et al.. (1999). Economic Evaluation of Donepezil for the Treatment of Alzheimer's Disease in Canada. Journal of the American Geriatrics Society. 47(5). 570–578. 101 indexed citations

19.

Hux, M, B O’Brien, Michaël Iskedjian, et al.. (1998). Relation between severity of Alzheimer's disease and costs of caring.. PubMed. 159(5). 457–65. 193 indexed citations

20.

Gafni, Amiram, Ron Goeree, Terri L. Myhr, et al.. (1997). Induction of labour versus expectant management for prelabour rupture of the membranes at term: an economic evaluation. TERMPROM Study Group. Term Prelabour Rupture of the Membranes.. PubMed. 157(11). 1519–25. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact